[AVTE] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[AVTE] Aerovate Therapeutics, Inc.
Announcement Date
15-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -2.52%
YoY- -42.59%
Quarter Report
AVTE's Result
AVTE's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 136 0 0 0 0 0 0 -
PBT -20,357 -19,563 -19,025 -16,520 -14,997 -13,588 -11,991 42.17%
Tax 56 -25 -1,312 -1,119 25 -564 -224 -
NP -20,413 -19,563 -19,025 -15,401 -15,022 -13,024 -11,767 44.23%
Tax Rate - - - - - - - -
Total Cost 20,549 19,563 19,025 15,401 15,022 13,024 11,767 44.86%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -15,009.56 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.74 -0.71 -0.76 -0.62 -0.61 -0.53 -0.48 33.34%
EPS Diluted -0.74 -0.71 -0.76 -0.62 -0.61 -0.53 -0.48 33.34%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.